Mayo Clinic Cancer Center reports advancements and solutions for quality of life assessments

December 09, 2005

Mayo Clinic Cancer Center researchers recently published the first series of chapters in a two-part monograph discussing quality of life (QOL) assessment -- best practices, promising techniques and revolutionary applications. The monograph was published in the November-December issue of Current Problems in Cancer, with the second half to follow in early 2006.

"Quality of life assessment is integral to the successful treatment of cancer patients," says Jeff Sloan, Ph.D., Mayo Clinic oncology researcher. "While for many years clinicians have been collecting QOL data and using it in various ways, we now see a concerted effort to capture that information in common ways throughout the discipline. Our hope is that this series of papers will facilitate understanding of QOL assessment and subsequent use for improving patient care."

The authors define QOL as an overarching term referring to all aspects of a cancer patient's well-being, other than survival or tumor response. They tackle philosophical issues as well as issues of statistical relevance and data collection. Practical examples enable the reader to easily grasp the concepts they review or introduce. They review current understandings, recent advances and where QOL assessment discussion is likely to go in the future.

Issues addressed in this first of two publications include: Dr. Sloan and his co-authors say the need for accurate and complete QOL assessments that provide valuable health information must be balanced with the issue of time and mental burden on the patient required to complete the assessments. To be useful, they say that any means of measuring QOL must include the researcher, clinician and patient perspectives -- which heretofore have often been ignored in the quest for statistical information.

"It is as important to address the patient's feelings and physical symptoms as it is to attack the cancer itself," says Dr. Sloan. "We found that literature and anecdotal information supported this over and over again, and we tried to answer some of the concerns and questions that may have hindered clinicians' application of QOL assessments in the past."

Cancer survivors were included in the authorship of the series, providing the patient's perspective to show how integrating QOL assessments in the clinical setting will help clinicians fully address the needs of each patient. "It is wonderful to see more and more research and practical application of QOL assessments," says Wayland Eppard, bladder cancer survivor and patient advocate for the North Central Cancer Treatment Group. "I hope that doctors will be able to use this monograph to provide more personalized care for their patients."
Sloan and Eppard were joined in researching and writing the monologue by Mayo Clinic colleagues: Amylou Dueck, Ph.D.; Marlene Frost, Ph.D.; Michele Halyard, M.D.; Pamela Atherton; Kelli Burger; Jef Huntington; Mashele Huschka; Celia Kamath, Ph.D.; Sumithra Mandrekar, Ph.D.; Paul Novotny; Denise Smith; Angelina Tan; and Cathy (Xinghau) Zhao. Ms. Cynthia Chauhan, patient advocate for the North Central Cancer Treatment Group also contributed.

To obtain the latest news releases from Mayo Clinic, go to ( is available as a resource for your health stories.

Mayo Clinic

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to